| Analysis | Metabolite Name | Measured Value | Units | GROUP_ID |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.6396 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.7699 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.8339 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.8516 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.9355 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.1063 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.1947 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.2296 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.2986 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.4116 | Relative Abundance | CON |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|